Revolo Biotherapeutics

About:

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing.

Website: https://revolobio.com/

Twitter/X: revolobio

Top Investors: 24 Haymarket, Morningside Venture Investments, NCL Technology Ventures, Metellus

Description:

Revolo Biotherapeutics has developed therapies that achieve superior long-term disease remission from less frequent chronic dosing and without suppression of the immune system. Its mission is to revolutionize autoimmune and allergic disease treatment by resetting the immune system for superior long-term disease remission. Revolo Biotherapeutics was founded in 2011 and formerly known as Immune Regulation.